Search results
Results from the WOW.Com Content Network
Methamphetamine is available in the United States under the brand-name of Desoxyn, distributed by Key Therapeutics. While there is technically no difference between the laws regarding methamphetamine and other controlled stimulants, most medical professionals are averse to prescribing it due to its notoriety.
Methamphetamine is FDA approved for the treatment of ADHD and exogenous obesity. It is dispensed in the USA under the trademark name "Desoxyn" [22] and manufactured by Ovation Pharmaceuticals. [23] The levorotary form of methamphetamine, called levomethamphetamine, is an over-the-counter drug used in nasal decongestants inhalers. [24]
Signed into law by President George W. Bush on March 9, 2006 The Combat Methamphetamine Epidemic Act of 2005 ( CMEA ) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs:
The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs (see DEA Schedules).It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs.
Methamphetamine was discovered in 1893 and exists as two enantiomers: levo-methamphetamine and dextro-methamphetamine. [ note 2 ] Methamphetamine properly refers to a specific chemical substance, the racemic free base , which is an equal mixture of levomethamphetamine and dextromethamphetamine in their pure amine forms, but the hydrochloride ...
Search the web. Legal Main; Terms of Service Summary; Terms of Service; Legal Information Privacy Policy. Privacy Policy Highlights
U.S. Customs and Border Protection officers in California discovered $5 million worth of methamphetamine disguised as watermelons last week, the agency said Tuesday.
The Comprehensive Methamphetamine Control Act of 1996 is a bill enacted into law (Pub. L. 104–237 (text)) by the 104th Congress of the United States. It mandated registration of persons trading in list I chemicals from the DEA list of chemicals. [1] A fee for such registration was initially $595 but later reduced to $116.